Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017

被引：15
|
作者：
Frank I. Scott
Gary R. Lichtenstein
机构：
[1] University of Colorado Anschutz Medical Campus,Crohn’s and Colitis Center, Division of Gastroenterology and Hepatology
[2] Perelman School of Medicine,Gastroenterology Division
[3] University of Pennsylvania,undefined
来源：
Current Treatment Options in Gastroenterology | 2018年 / 16卷 / 1期
关键词：
Biosimilars; Indication extrapolation; Interchangeability; Infliximab; Adalimumab; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis;
D O I：
10.1007/s11938-018-0177-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 164
页数：17
相关论文
共 50 条
  • [41] Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
    Al Sulais, Eman
    AlAmeel, Turki
    BIOLOGICS-TARGETS & THERAPY, 2020, 14 : 1 - 11
  • [42] BIOSIMILARS SLOW TO GAIN TRACTION FOR INFLAMMATORY BOWEL DISEASE IN THE US
    Zweig, Steven J.
    BIOTECHNOLOGY LAW REPORT, 2020, 39 (03) : 163 - 163
  • [43] Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review
    Radin, Massimo
    Sciascia, Savino
    Roccatello, Dario
    Cuadrado, Maria Jose
    BIODRUGS, 2017, 31 (01) : 37 - 49
  • [44] The European Perspective and History on Biosimilars for the Treatment of Inflammatory Bowel Diseases
    Solitano, Virginia
    D'Amico, Ferdinando
    Da Rio, Leonardo
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CROHNS & COLITIS 360, 2021, 3 (01)
  • [45] Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review
    Massimo Radin
    Savino Sciascia
    Dario Roccatello
    Maria Jose Cuadrado
    BioDrugs, 2017, 31 : 37 - 49
  • [46] Does the Introduction of Biosimilars Change Our Understanding about Treatment Modalities for Inflammatory Bowel Disease?
    Buer, L.
    Hoivik, M. L.
    Medhus, A. W.
    Moum, B.
    DIGESTIVE DISEASES, 2017, 35 (1-2) : 74 - 82
  • [47] Supporting travel in patients with inflammatory bowel disease
    Mushtaq, Ammara
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (07): : 499 - 500
  • [48] Recent trends (2016-2017) in the treatment of inflammatory bowel disease
    Masaki, Tadahiko
    Kishiki, Tomokazu
    Kojima, Kouichiro
    Asou, Nobuyoshi
    Beniya, Ayumi
    Matsuoka, Hiroyoshi
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2018, 2 (04): : 282 - 288
  • [49] What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?
    Cary, Virginia A.
    Boullata, Joseph
    JOURNAL OF CLINICAL NURSING, 2010, 19 (7-8) : 904 - 916
  • [50] Treatment of inflammatory bowel disease in childhood:: Best available evidence
    Escher, JC
    Taminiau, JAJM
    Nieuwenhuis, EES
    Büller, HA
    Grand, RJ
    INFLAMMATORY BOWEL DISEASES, 2003, 9 (01) : 34 - 58
12345